AccessPak for HIV PEP Expanded with Viracept and Risankizumab-rzaa topical
Determining the interaction of AccessPak for HIV PEP Expanded with Viracept and Risankizumab-rzaa topical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / nelfinavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Viracept
Synonyms: n.a.
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Risankizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Viracept-Risedronate
- AccessPak for HIV PEP Expanded with Viracept-Risedronate and Calcium
- AccessPak for HIV PEP Expanded with Viracept-Risedronate Delayed Release
- AccessPak for HIV PEP Expanded with Viracept-Risedronate Delayed-Release Tablets
- AccessPak for HIV PEP Expanded with Viracept-Risedronate Sodium
- AccessPak for HIV PEP Expanded with Viracept-Risedronate Tablets
- Risankizumab-rzaa topical-Accolate
- Risankizumab-rzaa topical-Accretropin
- Risankizumab-rzaa topical-Accucaine
- Risankizumab-rzaa topical-AccuHist Drops
- Risankizumab-rzaa topical-AccuHist PDX Drops
- Risankizumab-rzaa topical-AccuHist PDX Syrup